1 |
Choudhary, D., Chandra, D. and Kale, R.K. (1997) Influence of methylglyoxal on antioxidant enzymes and oxidative damage. Toxicol. Lett., 93, 141-152.
DOI
ScienceOn
|
2 |
Rej, R. (1978) Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin. Chem., 24, 1971-1979.
|
3 |
Cheng, A.S., Cheng, Y.H., Chiou, C.H. and Chang, T.L. (2012) Resveratrol upregulates Nrf2 Expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. J. Agric. Food Chem., 60, 9180-9187.
DOI
ScienceOn
|
4 |
Masterjohn, C., Mah, E., Park, Y., Pei, R., Lee, J., Manautou, J.E. and Bruno, R.S. (2013) Acute glutathione depletion induces hepatic methylglyoxal accumulation by impairing its detoxification to D-lactate. Exp. Biol. Med. (Maywood), 238, 360-369.
DOI
|
5 |
Li, W., Xu, H., Hu, Y., He, P., Ni, Z., Xu, H., Zhang, Z. and Dai, H. (2013) Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress. PLoS One, 8, e76025.
DOI
|
6 |
Fiory, F., Lombardi, A., Miele, C., Giudicelli, J., Beguinot, F. and Van Obberghen, E. (2011) Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia, 54, 2941-2952.
DOI
ScienceOn
|
7 |
Li, W., Maloney, R.E., Circu, M.L., Alexander, J.S. and Aw, T.Y. (2013) Acute carbonyl stress induces occludin glycation and brain microvascular endothelial barrier dysfunction: role for glutathione-dependent metabolism of methylglyoxal. Free Radical Biol. Med., 54, 51-61.
DOI
ScienceOn
|
8 |
Sorci, G., Riuzzi, F., Giambanco, I. and Donato, R. (2013) RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys. Acta, 1833, 101-109.
DOI
ScienceOn
|
9 |
Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2012) The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vasc. Pharmacol., 57, 160-167.
DOI
ScienceOn
|
10 |
Ren, J., Pulakat, L., Whaley-Connell, A. and Sowers, J.R. (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med., 88, 993-1001.
DOI
ScienceOn
|
11 |
Kim, J.S., He, L. and Lemasters, J.J. (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun., 304, 463-470.
DOI
ScienceOn
|
12 |
Lemasters, J.J., Nieminen, A.L., Qian, T., Trost, L.C., Elmore, S.P., Nishimura, Y., Crowe, R.A., Cascio, W.E., Bradham, C.A., Brenner, D.A. and Herman, B. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta, 1366, 177-196.
DOI
ScienceOn
|
13 |
Shin, S.M., Cho, I.J. and Kim, S.G. (2009) Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase- inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol., 76, 884-895.
DOI
ScienceOn
|
14 |
Yu, S.W., Wang, H., Poitras, M.F., Coombs, C., Bowers, W.J., Federoff, H.J., Poirier, G.G., Dawson, T.M. and Dawson, V.L. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297, 259-263.
DOI
ScienceOn
|
15 |
Rolo, A.P. and Palmeira, C.M. (2006) Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol., 212, 167-178.
DOI
ScienceOn
|
16 |
Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D. and Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem., 269, 9889-9897.
|
17 |
Brouwers, O., Niessen, P.M., Ferreira, I., Miyata, T., Scheffer, P.G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C.D. and Schalkwijk, C.G. (2011) Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J. Biol. Chem., 286, 1374-1380.
DOI
ScienceOn
|
18 |
Meister, A. and Anderson. M.E. (1983) Glutathione. Annu. Rev. Biochem., 52, 711-760.
DOI
ScienceOn
|
19 |
Mukohda, M., Okada, M., Hara, Y. and Yamawaki, H. (2012) Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility. J. Pharmacol. Sci., 118, 303-310.
DOI
|
20 |
Ramasamy, R., Yan, S.F. and Schmidt, A.M. (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N.Y. Acad. Sci., 1243, 88-102.
DOI
ScienceOn
|
21 |
Ruggiero-Lopez, D., Lecomte, M., Moinet, G., Patereau, G., Lagarde, M. and Wiernsperger, N. (1999) Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation. Biochem. Pharmacol., 58, 1765-1773.
DOI
ScienceOn
|
22 |
Lee, B.H., Hsu, W.H., Chang, Y.Y., Kuo, H.F., Hsu, Y.W. and Pan, T.M. (2012) Ankaflavin: a natural novel PPARn agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radical Biol. Med., 53, 2008-2016.
DOI
ScienceOn
|
23 |
Jiang, G. and Zhang, B.B. (2003) Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab., 284, E671-678.
DOI
|
24 |
Marceau, P., Biron, S., Hould, F.S., Marceau, S., Simard, S., Thung, S.N. and Kral, J.G. (1999) Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab., 84, 1513-1517.
DOI
|
25 |
Rabbani, N. and Thornalley, P.J. (2011) Glyoxalase in diabetes, obesity and related disorders. Semin. Cell Dev. Biol., 22, 309-317.
DOI
ScienceOn
|
26 |
Pun, P.B., Logan, A., Darley-Usmar, V., Chacko, B., Johnson, M.S., Huang, G.W., Rogatti, S., Prime, T.A., Methner, C., Krieg, T., Fearnley, I.M., Larsen, L., Larsen, D.S., Menger, K.E., Collins, Y., James, A.M., Kumar, G.D., Hartley, R.C., Smith, R.A. and Murphy, M.P. (2014) A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes. Free Radical Biol. Med., 67, 437-450.
DOI
ScienceOn
|
27 |
Gaens, K.H., Stehouwer, C.D. and Schalkwijk, C.G. (2013) Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr. Opin. Lipidol., 24, 4-11
DOI
|
28 |
Shinohara, M., Thornalley, P.J., Giardino, I., Beisswenger, P., Thorpe, S.R., Onorato, J. and Brownlee, M. (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest., 101, 1142-1147.
DOI
ScienceOn
|
29 |
Tappy, L. and Le, K.A. (2012) Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res. Hepatol. Gastroenterol., 36, 554-560.
DOI
ScienceOn
|
30 |
Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G.E. and Vlassara, H. (2012) Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc. Natl. Acad. Sci. U.S.A., 109, 15888-15893.
DOI
|
31 |
Beisswenger, P.J., Howell, S.K., Touchette, A.D., Lal, S. and Szwergold, B.S. (1999) Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes, 48, 198-202.
DOI
ScienceOn
|
32 |
Yu, S.W., Andrabi, S.A., Wang, H., Kim, N.S., Poirier, G.G., Dawson, T.M. and Dawson, V.L. (2006) Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U.S.A., 103, 18314-18319.
DOI
ScienceOn
|